- Report
- February 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- October 2024
- 192 Pages
Global
From €3226EUR$3,545USD£2,766GBP
€3585EUR$3,939USD£3,073GBP
- Report
- October 2024
- 185 Pages
Global
From €3226EUR$3,545USD£2,766GBP
€3585EUR$3,939USD£3,073GBP
- Report
- February 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- February 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- November 2024
- 180 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- February 2022
- 80 Pages
Global
From €2503EUR$2,750USD£2,146GBP
€5006EUR$5,500USD£4,291GBP
- Report
- October 2023
- 171 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- January 2022
- 120 Pages
Global
From €4323EUR$4,750USD£3,706GBP
The Lipid Profile market is a subset of the Cholesterol Testing market. It is a type of blood test that measures the levels of lipids, such as cholesterol and triglycerides, in the body. It is used to assess the risk of developing cardiovascular diseases, such as heart attack and stroke. The test is typically ordered by a doctor to help diagnose and monitor lipid-related conditions.
The Lipid Profile market is highly competitive, with a range of companies offering products and services. These include Abbott Laboratories, Alere, Beckman Coulter, Bio-Rad Laboratories, Roche Diagnostics, Siemens Healthineers, and Thermo Fisher Scientific. Show Less Read more
